Macular thickness increases after cataract surgery

Article

Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.

Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.

Dr M. Gharbiya et al., Department of Ophthalmology, Sapienza University, Umberto I Hospital, Rome, Italy, conducted a prospective, non-randomized, clinical study on 40 patients undergoing uneventful phacoemulsification with fellow eyes used as controls.

OCT measurements were gathered before surgery and postoperatively at day 1, week 1 and 2 and month 1, 2, 3 and 6. The retinal map was split into central point thickness (CPT), central 1 mm subfield (CSF) and two peripheral ring areas with diametres of 3 and 6 mm.

Retinal thickness change between the fellow and operated eyes were compared using unpaired t-test and correlations were assessed using the Spearman or Pearson analysis.

The results revealed a progressive significant increase in retinal thickness in the operated eyes compared to the fellow eyes, peaking at one month for the 3 mm and 6 mm areas and at 2 months for CPT and CSF.

At six months retinal thickness was still significantly thicker than fellow eyes, but only in the peripheral areas. No significant correlations were recorded between macular thickness changes and preoperative factors, intraoperative factors or BCVA change. The most significant findings was the regional pattern of retinal thickening with an early involvement of the parafoveal area.

Please click here to read the abstract.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.